According to a new study, researchers found that the human papillomavirus vaccine can offer protection against the virus for at least eight years.
According to the early results from a phase I trial, a vaccine for the chikungunya virus could be available over the next five to 10 years.
An advisory panel voted in favor of recommending Pfizer's Prevnar 13 vaccine in order to protect seniors aged 65 and older against pneumococcal disease.
Researchers have identified new vaccine targets that could be of much help in the battle against malaria, according to a new study.
The results from an ongoing clinical trial found that the malaria vaccine was still able to protect children at 18 months.
A new study found that anal and throat cancers linked to HPV have been on the rise.
A new CDC report found that the HPV vaccination rates for boys and girls are still too low.
Researchers reported that an early trial testing the dengue fever vaccine shows promise.
Smallpox vials were discovered inside an old storage area in Bethesda, MD.
A new study found that the quadrivalent HPV vaccination does not increase women's risk of blood clots.
A new study concluded that vaccines are safe for children and do not cause health conditions such as autism and leukemia.
The CDC's advisory panel is recommending the nasal spray over the flu shot for children between the ages of two and eight.
The United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) has conditionally approved a new vaccine to fight pig virus this week.
According to a new study, a single jab combination vaccine increased seizure risk for toddlers.
Researchers, by tweaking a protein expressed by most liver cancer cells, have made a vaccine that is remarkably effective at preventing the disease in mice.